Clinical Trial Update: An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC) [EARLY_Phase 1]

View source ↗

Summary

This document describes an early-phase (Phase 1) exploratory clinical study evaluating the safety and potential efficacy of an allogeneic CAR-NK cell therapy fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Allogeneic CAR-NK cell therapy (CAR-NK cell therapy)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Prostate Cancer Castration-resistant Prostate Cancer | EARLY_Phase 1 | Status: RECRUITING